منابع مشابه
Schistosomiasis amongst Rhodesian troops.
obviate the necessity for the .operator to maintain pressure on the plunger was found to he ineffective after repeated trials. The syringe described by W. O. Gross (1954) seems to offer an advance in mass inoculation technique in that it provides a more rapid method than others described. Again, however, with this syringe the thumb must control the plunger carefully during injection and withdra...
متن کاملEXTENSION IN A RHODESIAN PdRCHASE LAND AREA
A study is presented which assesses agricultural production in a Purchase Land area over a seven-year period and tries to identify certain socio-psychological and other variables which might be acting as constraints on farming behavior in terms of change. A survey was conducted of the whole population of 198 resident farm families; it included six questionnaires. Subjects covered included agric...
متن کاملInheritance of dermoid sinus in the Rhodesian ridgeback.
OBJECTIVES TO define the mode of inheritance of dermoid sinus. METHODS A chi-squared analysis was performed on data from 46 litters produced between 1990 and 2001. Data were corrected to avoid bias in the segregation ratio. RESULTS In data from 57 litters (n=492), 82 dermoid sinus positive offspring were observed. The frequency of affected offspring in the Swedish Rhodesian ridgeback popula...
متن کاملPrevalence of asthma in Rhodesian Africans.
The prevalence of asthma in a small African town has been assessed using two questionnaires. The first was put to 9768 subjects aged 5 years and older and the second, more detailed, questionnaire to random selections of these subjects grouped according to their replies. The overall prevalence of asthma was 1.40%. In those under 20 years of age it was 1.20% and in adults, 1.57%. This adult rate ...
متن کاملTreatment of Rhodesian sleeping sickness in Kenya.
In a study of 269 sleeping sickness patients treated with Mel-B, 14 (5.2%) died during treatment. With total dosages of at least 30 ml (1.08 g), 1.4% relapsed and another 6.4% died, mostly of unknown causes, within three years of treatment, giving a success rate of 92.1% over the three years. Mel-B was used to treat 55 relapses after suramin therapy with 1.8% deaths during treatment, 3.6% relap...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1922
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.1.3188.197